Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19741296 | 1.00 | LMNA (0.36) | LMNAL3MBTL1TDP1MGAMKDM4E | |
| SCHEMBL14159253 | 1.00 | LMNA (0.36) | LMNAL3MBTL1TDP1MGAMKDM4E | |
| SCHEMBL13324584 | 0.84 | LMNA (0.55) | LMNAL3MBTL1TDP1MGAMKDM4E | |
| SCHEMBL1317309 | 0.84 | MGAM (0.39) | TDP1MGAM | |
| SCHEMBL12831105 | 0.84 | LMNA (0.55) | LMNAL3MBTL1TDP1MGAMKDM4E | |
| SCHEMBL19741235 | 0.84 | LMNA (0.55) | LMNAL3MBTL1TDP1MGAMKDM4E | |
| SCHEMBL19741237 | 0.84 | LMNA (0.55) | LMNAL3MBTL1TDP1MGAMKDM4E | |
| SCHEMBL11147863 | 0.84 | LMNA (0.55) | LMNAL3MBTL1TDP1MGAMKDM4E | |
| SCHEMBL23603151 | 0.83 | MGAM (0.31) | MGAM | |
| SCHEMBL6742636 | 0.83 | MGAM (0.34) | MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102294-A1 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-16 | — | — | US | disclosed |
| US-12533269-B2 | Absorbent article comprising a fragrance and an odor control composition | THE PROCTER & GAMBLE COMPANY (US) | 2026-01-27 | — | — | US | disclosed |
| US-12350135-B2 | Absorbent article with odor control composition | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | disclosed |
| US-20240115437-A1 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2024-04-11 | — | — | US | disclosed |
| US-11590254-B2 | Absorbent articles comprising encapsulating agents | THE PROCTER & GAMBLE COMPANY (US) | 2023-02-28 | — | — | US | disclosed |
| US-20230042590-A1 | ABSORBENT ARTICLE WITH ODOR CONTROL COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2023-02-09 | — | — | US | disclosed |
| EP-3474906-B1 | ABSORBENT ARTICLE COMPRISING CYCLODEXTRIN COMPLEXES | PROCTER & GAMBLE (US) | 2020-10-21 | — | — | EP | disclosed |
| EP-3474907-B1 | ABSORBENT ARTICLE COMPRISING CYCLODEXTRIN COMPLEXES | PROCTER & GAMBLE (US) | 2020-08-12 | — | — | EP | disclosed |
| US-10427133-B2 | Absorbent article comprising cyclodextrin complexes | THE PROCTER & GAMBLE COMPANY (US) | 2019-10-01 | — | — | US | disclosed |
| EP-3474907-A1 | ABSORBENT ARTICLE COMPRISING CYCLODEXTRIN COMPLEXES | The Procter and Gamble Company (US) | 2019-05-01 | — | — | EP | disclosed |
| EP-3474906-A1 | ABSORBENT ARTICLE COMPRISING CYCLODEXTRIN COMPLEXES | The Procter and Gamble Company (US) | 2019-05-01 | — | — | EP | disclosed |
| EP-3474908-A1 | ABSORBENT ARTICLES COMPRISING ENCAPSULATING AGENTS | The Procter and Gamble Company (US) | 2019-05-01 | — | — | EP | disclosed |
| US-10183273-B2 | Absorbent article comprising cyclodextrin complexes | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-22 | — | — | US | disclosed |
| US-20180333515-A1 | ABSORBENT ARTICLES COMPRISING ENCAPSULATING AGENTS | PROCTER & GAMBLE (US) | 2018-11-22 | — | — | US | disclosed |
| WO-2017223443-A1 | ABSORBENT ARTICLE COMPRISING CYCLODEXTRIN COMPLEXES | THE PROCTER & GAMBLE COMPANY (US) | 2017-12-28 | — | — | WO | disclosed |
| WO-2017223444-A1 | ABSORBENT ARTICLES COMPRISING ENCAPSULATING AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 2017-12-28 | — | — | WO | disclosed |
| WO-2017223439-A1 | ABSORBENT ARTICLE COMPRISING CYCLODEXTRIN COMPLEXES | THE PROCTER & GAMBLE COMPANY (US) | 2017-12-28 | — | — | WO | disclosed |
| US-20170368218-A1 | Absorbent Article Comprising Cyclodextrin Complexes | THE PROCTER & GAMBLE COMPANY | 2017-12-28 | — | — | US | disclosed |
| US-20170368532-A1 | Absorbent Article Comprising Cyclodextrin Complexes | THE PROCTER & GAMBLE COMPANY | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12533269-B2 | Absorbent article comprising a fragrance and an odor control composition | CUTA, CFD, MBTD1 | LMNA 2623/4885L3MBTL1 3765/4885TDP1 2588/4885 |
| US-20260102294-A1 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION | CUTA, SHBG, DSG1 | LMNA 2880/4885L3MBTL1 4442/4885TDP1 3090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.